ABBVAbbVie
About AbbVie
AbbVie (NYSE:ABBV) is a global biopharmaceutical business specializing in the research, development, production and distribution of advanced therapies for complex health issues. Its operations span various therapeutic areas including immunology, oncology, and virology among others. Key projects involve developing innovative, targeted treatments for conditions like rheumatoid arthritis, psoriasis, HIV, and numerous forms of cancer. AbbVie's overarching objective is to improve lives by providing solutions to the world's most pressing health challenges, offering breakthrough treatments in some of the most challenging fields of medicine.
What is ABBV known for?
Snapshot
Public US
Ownership
2012
Year founded
53754
Employees
North Chicago, United States
Head office
1 of 4
US Rank
Unknown
Sector
N/A
Sector rank
Loading Map...
Operations
All Locations
United States
Produtos e/ou serviços de AbbVie
- Humira (adalimumab): This injectable medication is used to treat various chronic inflammatory conditions, including rheumatoid arthritis, Crohn's disease, ulcerative colitis, psoriasis, and ankylosing spondylitis. It is AbbVie's top-selling drug and one of the best-selling drugs globally.
- Skyrizi (risankizumab): This is another biologic medication used to treat psoriasis, psoriatic arthritis, and Crohn's disease. It works by targeting interleukin-23, a protein that plays a role in inflammation.
- Ubrelvy (ubrogepant): This oral medication is used to treat acute migraine attacks. It works by blocking a protein involved in pain transmission in the brain.
- Botox (onabotulinumtoxinA): This injectable toxin is used for a variety of cosmetic and medical purposes, including treating wrinkles, chronic migraines, excessive sweating, and muscle spasticity. AbbVie acquired Allergan, the original manufacturer of Botox, in 2020.
- Lupron (leuprolide acetate): This injectable medication is used to treat prostate cancer, endometriosis, and precocious puberty. It works by suppressing the production of testosterone and other sex hormones.
- Vuity (apitelirsen): This oral medication is the first and only approved treatment for wet age-related macular degeneration (AMD), a leading cause of vision loss in older adults.
equipe executiva do AbbVie
- Mr. Robert A. Michael CPACEO & Chairman of the Board
- Mr. Scott T. ReentsExecutive VP & CFO
- Dr. Azita Saleki-Gerhardt Ph.D.Executive VP & COO
- Mr. Jeffrey Ryan StewartExecutive VP & Chief Commercial Officer
- Dr. Roopal Thakkar M.D.Executive VP of Research and Development & Chief Scientific Officer
- Ms. Elizabeth SheaSenior Vice President of Investor Relations
- Mr. Perry C. SiatisExecutive VP, General Counsel & Secretary
- Mr. Demetris D. CrumExecutive VP & Chief Human Resources Officer
- Mr. Wulff-Erik von BorckeSenior VP & President of Oncology
- Dr. Nicholas J. Donoghoe M.D.Executive VP and Chief Business & Strategy Officer